Welcome: Wuhan Acome Biotechnology Co., Ltd.
info@acomebio.com +8615807175144

Rimonabant (Acomplia) powder

Rimonabant powder, Rimonabant (Acomplia) powder for fat loss
Contact: info@acomebio.com, Wickr Me: acomebio
CAS No: 168273-06-1
Molecular Formula: C22H21Cl3N4O
Molecular Weight: 463.79g/mol
Purity: >99%
Appearance: White Crystalline powder.
Origin: China
Payment: WU,MG, TT, Bitcoin, Paypal
Transport Package: Aluminum Foil Bag or as Required
Usage: Rimonabant (Acomplia) powder For Weight Loss


Raw Rimonabant (Acomplia) powder for Fat loss for sale


Rimonabant Hydrochloride is a cannabinoid receptor (CB1) antagonist. Rimonabant (Acomplia) reduces appetite and smoking cravings by blocking cannabinoid receptors in brain tissue. Rimonabant (Acomplia) can be used for obesity, smoking cravings, high blood pressure, and blood lipids. The treatment of abnormal and type 2 diabetes and metabolic syndrome can reduce cholesterol at the same time, and has the effect of preventing heart disease and diabetes in obese people. Rimonabant (Acomplia) was listed in Chemicalbook in 2006 in many countries. In addition, basic and clinical studies have confirmed that Rimonabant (Acomplia) can effectively improve hyperglycemia, insulin resistance and lipid metabolism disorders associated with obesity. However, the current understanding of the above-mentioned mechanism of action of Rimonabant (Acomplia) is still superficial, and the more precise mechanism still needs to be further studied and clarified. In view of its obvious economic benefits and social value, the development of the synthetic process of Rimonaban hydrochloride with industrialization potential has broad market prospects.

Rimonabant (Acomplia) Usage

Rimonabant (Acomplia) is a weight-loss drug, successfully developed by the French company Sanofi-Aventis. Rimonabant (Acomplia) is also the first cannabinoid type 1 receptor (CB1) antagonist used in the treatment of obesity, which selectively blocks cannabis in the EC system CannabiChemicalbooknoid-1 (CB1) receptors, which can significantly reduce body weight, reduce waist circumference, reduce cardiovascular disease and other risk factors, and can also improve blood lipids, insulin resistance, and metabolic syndrome. Rimonabant (Acomplia) is especially suitable for People at risk of clinical obesity or heart disease.

Rimonabant (Acomplia) is a new weight-loss drug and can be used to quit smoking. A new weight-loss drug, Rimonabant (Acomplia), can not only lose weight, but also Chemicalbook can lower blood pressure, cholesterol and blood sugar. A clinical study conducted in China for more than a year found that after taking one to two months, The average weight can be reduced by six to eight kilograms.